New: Biosimilars strategies introduced.
Close
Valuable and timely information on drug therapy issues impacting today's health care and pharmacy environment.
April 16, 2018 - The FDA announced the discontinuation of Hospira’s Talwin (pentazocine) 30 mg/mL injection.
Download PDF
Return to publications
